KYSO ANTIBODIES Trademark
KYSO ANTIBODIES is a USPTO trademark filed by Genmab A/S. Status: Registered.
Prosecution Summary
Trademark Summary
The mark is KYSO ANTIBODIES (word mark), and it is disclaimed for “ANTIBODIES”. The owner is AKTIESELSKAB (Genmab A/S). The application (U.S. Application No. 79353559) is registered, with the registration date January 30, 2024, and the current status is described as registered. The services/goods span multiple classes, including biological preparations for in vitro and in vivo research and development with regard to diseases, biochemical reagents and chemicals for biotechnological product development, and pharmaceutical and veterinary preparations including antibody-based preparations for prevention and treatment of various disorders (including cancer, autoimmune diseases, and inflammatory disorders); it also includes medical and scientific r
Trademark Facts
| Mark | KYSO ANTIBODIES |
|---|---|
| Serial Number | 79353559 |
| Registration Number | 7292381 |
| Status | Registered |
| Filing Date | 2022-08-10 |
| Registration Date | 2024-01-30 |
| Mark Type | Word |
| Nice Classes | 001 (Chemicals), 005 (Pharmaceuticals), 042 (Software & IT), 045 (Legal Services) |
| Owner | Genmab A/S |
| Attorney of Record | Max Vern |
| Prosecution Events | 31 |
| Latest Event | MAFRO on 2025-03-21 |
Goods & Services
Class 001: Biological preparations for use in industry and science for in vitro and in vivo scientific and industrial research and development with regard to diseases; biochemical preparations for in vitro and in vivo scientific research purposes with regard to diseases; biochemical reagents used for non-medical purposes in the nature of in vitro and in vivo scientific and industrial research with regard to diseases; chemicals for use in biotechnological product development in the nature of in vitro and in vivo industrial product development with regard to diseases; active chemical ingredients for use in the manufacture of pharmaceuticals for the treatment of cancer, autoimmune diseases, and inflammatory disorders; Class 005: Pharmaceutical and veterinary preparations including preparations based on antibodies, and bi- and multi-specific antibodies as well as fragments, derivatives and conjugates thereof, namely, pharmaceutical products for the prevention and treatment of disorders of the nervous system, the immune system, the cardio-vascular system, the metabolic system, the respiratory system, the musculo-skeletal system, and the genitourinary system; Pharmaceutical and veterinary preparations, including preparations based on antibodies, and bi- and multi- specific antibodies as well as fragments, derivatives and conjugates thereof, for the treatment of cancer, autoimmune diseases, and inflammatory disorders; Class 042: Medical, scientific and biological research in the fields of antibodies, and bi- and multi-specific antibodies as well as fragments, derivatives and conjugates thereof and development of pharmaceutical products based on the same; chemical analysis; computer programming, namely, programming of computers for the collection and processing of medical data for use in medical scientific research, development and therapy and scientific research, development and therapy with antibodies and bi- and multi- specific antibodies as well as fragments, derivatives or conjugates of any of these; Class 045: Legal services relating to the exploitation of patents and licensing of intellectual property in the field of medicine